GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt · Delayed Price · Currency is EGP 73.41
-1.38 (-1.85%)
At close: Jul 14, 2026
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 7.36 billion as of July 15, 2026. Its market cap has increased by 133.35% in one year.
Market Cap
7.36B
Enterprise Value
6.96B
Revenue
3.73B
Ranking
n/a
PE Ratio
34.50
Stock Price
73.41
Market Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 7.36B, an increase of 1,191.90%. That is a compound annual growth rate of 13.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 6.13B | 15.33% |
| Dec 31, 2025 | 5.32B | 76.81% |
| Dec 31, 2024 | 3.01B | 1.27% |
| Dec 31, 2023 | 2.97B | -6.84% |
| Dec 29, 2022 | 3.19B | 23.58% |
| Dec 30, 2021 | 2.58B | 82.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition